Natco Pharma soars as path to launch Revlimid generic clears
Fri, Sep 18, 2020 1:51 PM

Natco Pharma soars as path to launch Revlimid generic clears

A Flip by Flipitnews
Get it on Google Play
The settlement of Dr Reddy’s Labs with Celgene over its patent on Revlimid cleared the path for Natco to launch the first generic version of the drug which is used to treat multiple myeloma and myelodysplastic syndromes. Following the settlement, shares of Natco Pharma surged 15.56 per cent to Rs 893.60. During the day it also hit the 20 per cent upper circuit placed at Rs 931.70.

More great flips

ITC Hotels Demerger: ITC to hold meeting of ordinary shareholders on June 6

ITC Hotels Demerger: ITC to hold meeting of ordinary shareholders on June 6

Cigarette-to-FMCG conglomerate ITC will convene a meeting of the company’s ordinary shareholders on June 6, 2024, to approve the proposed scheme of arrangement involving the demerger of ITC Hotels from ITC Limited into a separate listed subsidiary, the company on Wednesday said in an exchange filing.The meeting will be held at 10:30 am India time through the electronic mode

Open Flip
US judge approves $418 million antitrust settlement against National Asset

US judge approves $418 million antitrust settlement against National Asset

A U.S. federal judge in Missouri on Tuesday preliminarily approved an antitrust class-action settlement that requires the National Association of Realtors to pay $418 million and implement changes to how Americans buy and sell homes.Why it's Important U.S. District Judge Stephen Bough's settlement order marked a key first step in a months-long process that will culminate.

Open Flip
Vijay Kedia’s portfolio multibagger penny stock with Rs 19,134.7 cr order

Vijay Kedia’s portfolio multibagger penny stock with Rs 19,134.7 cr order

Patel Engineering Limited is issuing equity shares with a face value of Rs 1 each through a Qualified Institutional Placement (QIP). This issuance is authorized under various regulations including SEBI ICDR, Companies Act 2013, and PAS Rules. The board of directors approved the issuance on February 12, 2024, and shareholders approved it through a special meeting on March 8, 2024.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon